Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
3 studies found for:    22649152 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Magnetic Resonance Imaging in Women Receiving Chemotherapy for Stage III Breast Cancer
Condition: Breast Cancer
Interventions: Procedure: MRI/MRS;   Radiation: gadopentetate dimeglumine
2 Active, not recruiting Diagnostic Procedures in Women With Locally Advanced Breast Cancer Who Are Receiving Chemotherapy Before Breast Cancer Surgery
Condition: Breast Cancer
Interventions: Procedure: biopsy;   Procedure: magnetic resonance imaging;   Procedure: radiomammography;   Procedure: ultrasound imaging;   Radiation: gadopentetate dimeglumine;   Drug: chemotherapy
3 Recruiting I-SPY 2 TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
Conditions: Breast Neoplasms;   Breast Cancer;   Breast Tumors
Interventions: Drug: Standard Therapy;   Drug: AMG 386 with or without Trastuzumab;   Drug: AMG 479 (Ganitumab) plus Metformin;   Drug: MK-2206 with or without Trastuzumab;   Drug: AMG 386 and Trastuzumab;   Drug: T-DM1 and Pertuzumab;   Drug: Pertuzumab and Trastuzumab;   Drug: Ganetespib;   Drug: ABT-888;   Drug: Neratinib;   Drug: PLX3397;   Drug: Pembrolizumab;   Drug: Talazoparib plus Irinotecan;   Drug: Patritumab and Trastuzumab

Study has passed its completion date and status has not been verified in more than two years.